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Picornavirus RNA replication requires the formation of replication complexes (RCs) consisting of virus-
induced vesicles associated with viral nonstructural proteins and RNA. Brefeldin A (BFA) has been shown to
strongly inhibit RNA replication of poliovirus but not of encephalomyocarditis virus (EMCV). Here, we
demonstrate that the replication of parechovirus 1 (ParV1) is partly resistant to BFA, whereas echovirus 11
(EV11) replication is strongly inhibited. Since BFA inhibits COPI-dependent steps in endoplasmic reticulum
(ER)-Golgi transport, we tested a hypothesis that different picornaviruses may have differential requirements
for COPI in the formation of their RCs. Using immunofluorescence and cryo-immunoelectron microscopy we
examined the association of a COPI component, -COP, with the RCs of EMCV, ParV1, and EV11. EMCV RCs
did not contain -COP. In contrast, -COP appeared to be specifically distributed to the RCs of EV11. In
ParV1-infected cells -COP was largely dispersed throughout the cytoplasm, with some being present in the
RCs. These results suggest that there are differences in the involvement of COPI in the formation of the RCs
of various picornaviruses, corresponding to their differential sensitivity to BFA. EMCV RCs are likely to be
formed immediately after vesicle budding from the ER, prior to COPI association with membranes. ParV1 RCs
are formed from COPI-containing membranes but COPI is unlikely to be directly involved in their formation,
whereas formation of EV11 RCs appears to be dependent on COPI association with membranes.
All positive-stranded RNA viruses examined so far modify
intracellular membranes of their host cells to create vesicular
structures (replication complexes) in which viral RNA replica-
tion takes place. The replication complexes formed by viruses
of different families have diverse morphology, and membranes
of different cellular compartments undergo proliferation and
reorganization in the process of their formation (6, 7, 11, 29,
38, 45).
The Picornaviridae are a family of positive-stranded RNA
viruses, currently divided into nine genera (22). Most of the
data on RNA replication of picornaviruses has been obtained
in studies with Poliovirus (PV) (a member of the Enterovirus
genus). The replication complexes isolated from PV-infected
cells appear as rosette-like assemblies of heterogeneous-size
vesicles associated with viral nonstructural proteins and RNA
(3, 4). The exact origin of these vesicles is not clear. Rust et al.
have demonstrated that early in PV infection, vesicles carrying
viral nonstructural proteins are formed at the endoplasmic
reticulum (ER) by the cellular COPII budding mechanism and
thus are homologous to the vesicles of the anterograde mem-
brane transport pathway (43). These findings are in contrast to
some earlier studies, which suggested an autophagic mecha-
nism for the formation of virus-induced vesicles from the ER
(9, 46, 50). At later times in PV infection, when vesicle forma-
tion and RNA synthesis are at their peaks, all cytoplasmic
membranes, except the nuclear and plasma membranes and
mitochondria, are no longer recognizable (9). At this stage of
infection, cellular protein markers of the ER, trans-Golgi, and
lysosomes have been found within the PV-induced membranes
(46).
Infection of cells with PV causes an inhibition of cellular
protein secretion (13). Nevertheless, the virus appears to re-
quire some cellular components of the secretory pathway for
RNA replication. Brefeldin A (BFA), an inhibitor of secretory
membrane traffic in normal cells, strongly inhibits PV RNA
synthesis in infected cells, but not viral entry, translation, or
morphogenesis (21, 33, 52). This effect of BFA on PV replica-
tion is due to the inhibition of a required cellular factor, as PV
replication in BFA-resistant cell lines is not affected (12).
In mammalian cells secretory membrane traffic between the
ER and the Golgi is dependent on the function of two coat
protein complexes, COPI and COPII. In the anterograde di-
rection, ER cargo is packaged into COPII-coated vesicles that
bud from the ER and fuse either with a preexisting vesicular-
tubular cluster (VTC) (the functional equivalent of the inter-
mediate compartment) or with each other to form a VTC de
novo. In a second step, COPI binds to the VTC, and the
COPI-coated VTC, containing no detectable amounts of CO-
PII, travels to the Golgi complex (see reference 49 and refer-
ences therein). COPI binding is required also for the retrieval
of cycling proteins from the VTCs, the Golgi complex, and the
trans-Golgi network, such retrograde-directed cargo probably
being delivered to the ER in COPI-coated vesicles or uncoated
tubules (23, 24, 27, 36). BFA prevents membrane binding of
COPI and formation of COPI-coated vesicles by preventing
the membrane association of the GTPase ARF1, which is a
regulatory component of the COPI coat (14–17, 20, 37, 48).
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The formation of COPII-coated vesicles is not affected by BFA
(1, 35, 47, 53).
Cuconati et al. have shown that inhibition of PV RNA rep-
lication by BFA in a cell-free system is due to a requirement
for ARF activity for the formation of replication complexes
(8). This would suggest that COPI may be essential for PV
RNA replication. However, examination of two other picorna-
viruses, belonging to the Rhinovirus and Cardiovirus genera,
has shown that while Rhinovirus replication is also inhibited by
BFA, Cardiovirus replication is not affected (21). These results
suggest that picornaviruses of different genera may require
different cellular factors for RNA replication.
In this study, we demonstrate that the replication of Pare-
chovirus 1 (ParV1) (a member of the genus Parechovirus) is
partly resistant to the effect of BFA, but to a lesser degree than
that of Encephalomyocarditis virus (EMCV) (a member of the
genus Cardiovirus), whereas replication of Echovirus 11
(EV11) (a member of the genus Enterovirus) is strongly inhib-
ited. Using cryo-immunoelectron microscopy (cryo-IEM) and
confocal immunofluorescence (IF) microscopy we show that
COPI-coated membranes are segregated from the replication
complexes of EMCV, whereas ParV1 induces a diffusion of
COPI throughout the cytoplasm, some of it being present in
the replication complexes. In contrast, EV11 redistributes
COPI to the sites of RNA replication. Our results suggest that
COPI is directly involved in the formation of replication com-
plexes of enteroviruses, but not cardioviruses or parechovi-
ruses, which may explain the differences in BFA-sensitivity
observed between the three genera of picornaviruses.
MATERIALS AND METHODS
Infections and BFA treatment. Monolayers of BS-C-1 cells (African green
monkey kidney) were infected with EV11, ParV1, or EMCV at a multiplicity of
infection (MOI) of 3 PFU per cell. The viruses were allowed to absorb for 1 h at
37°C in minimal essential medium (MEM) (Gibco) containing 1% fetal bovine
serum (Gibco). The cells were then washed once with 10 mM Tris-HCl–150 mM
NaCl (pH 7.5), and further incubated at 37°C in serum-free MEM, either con-
taining BFA (10 g/ml; Sigma) or not, for the indicated periods of time (calcu-
lated starting from the moment of virus addition to the cells).
Time course of viral RNA synthesis. BS-C-1 cells were infected with EV11,
ParV1, or EMCV at an MOI of 3. After 1 h of virus absorption, the cells were
washed and incubated in MEM containing [5,6-3H]uridine (70 Ci/ml; Amer-
sham). The cells were lysed at different times postinfection (p.i.), and total
cytoplasmic RNA was extracted using an RNeasy kit (Qiagen) according to the
instructions of the manufacturer. The RNA was electrophoresed through a
formaldehyde–1% agarose gel and transferred to a Hybond-N membrane (Am-
ersham) by capillary action in 1.5 M NaCl–150 mM sodium citrate (pH 7.0) for
subsequent autoradiography.
Antibodies. Guinea pig polyclonal antibody raised against double-stranded
RNA (dsRNA) was kindly provided by J.-Y. Lee (Victorian Infectious Diseases
Reference Laboratory, Melbourne, Australia) (26). Monoclonal antibody to gi-
antin was a gift of H.-P. Hauri (University of Basel, Basel, Switzerland) (28).
Rabbit polyclonal antibody to -COP was purchased from Affinity BioReagents.
Immunofluorescence. BS-C-1 cells on coverslips were infected as above and
fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 10 min
at 20°C, followed by permeabilization with 0.2% Triton X-100 in 4% parafor-
maldehyde for 10 min at 20°C. Double IF staining was performed using goat
anti-guinea pig immunoglobulin G (IgG) antibody conjugated to Alexa Fluor 488
and goat anti-rabbit or anti-mouse IgG antibody conjugated to Alexa Fluor 568
(Molecular Probes). The images were obtained and processed using Radiance
2100 system for confocal microscopy (Bio-Rad).
Electron microscopy. For resin embedding, infected and uninfected cells were
harvested in PBS and fixed with 3% glutaraldehyde in PBS. The samples were
treated with 1% osmium tetroxide, dehydrated with ethanol, and embedded in
Epon 612 resin as previously described (31). The protocol for cryo-IEM was
described previously (30, 31). Briefly, cells were harvested in PBS and resus-
pended in 4% paraformaldehyde–0.2% glutaraldehyde in PBS. Cells were then
washed in PBS and embedded in 10% gelatin before cryofixation. Ultrathin
sections (50 nm) were collected in a 14:1 mix of 2.3 M sucrose and 2% methyl-
cellulose and immunolabeled, using anti-IgG gold (Biocell) or protein A-gold
(Utrecht University, Utrecht, Netherlands) for visualization. All specimens were
examined on JEOL 1010 transmission electron microscope at 80 kV.
RESULTS
Parechovirus 1 replicates in the presence of BFA. To exam-
ine whether BFA resistance is a unique property of the car-
dioviruses within the Picornaviridae family, we compared the
effect of BFA on the replication of EV11 (an Enterovirus),
EMCV (a Cardiovirus), and ParV1 (a Parechovirus).
BS-C-1 cells were infected with each virus at an MOI of 3
and treated with 10-g/ml BFA starting from 1 h p.i., or left
untreated. Samples were collected at 1-h intervals, and virus
production over time was measured by plaque assay. The re-
sults demonstrated a reduction of 5 orders of magnitude in
EV11 yield in the presence of BFA (from 2.7  107 PFU/ml to
2.7  102 PFU/ml), whereas EMCV production remained un-
affected (2.3  105 PFU/ml) (Fig. 1A and C). These results
were consistent with previously published data on PV and
EMCV (21, 33). ParV1 demonstrated resistance to BFA, how-
ever to a lower extent than EMCV: a 4-fold reduction in the
virus yield was observed in the presence of BFA (from 2.4 
107 PFU/ml to 6  106 PFU/ml) (Fig. 1B). BFA had no sig-
nificant effect on the time course of EMCV and ParV1 repli-
cation: virus production started and stopped at the same time
points in BFA-treated and untreated cells (Fig. 1B and C).
These results have shown that ParV1, like EMCV, is able to
replicate in the presence of BFA, whereas EV11 replication,
like PV replication, is strongly inhibited by BFA.
Effect of BFA on viral RNA synthesis. To compare the effect
of BFA on RNA replication between the three viruses, we first
selected the time points corresponding to the peak RNA syn-
thesis for each virus. For that purpose, BS-C-1 cells were in-
fected with each virus at an MOI of 3 and labeled with [5,6-
3H]uridine starting from 1 h p.i. Cytoplasmic RNA was
extracted from the cells at different times p.i. and analyzed by
formaldehyde-agarose gel electrophoresis and autoradiogra-
phy. The time courses showed maximal activity of viral RNA
synthesis between 5 and 6 h p.i for EV11, between 5 and 7 h p.i.
for ParV1, and between 7 and 8 h p.i. for EMCV (Fig. 2),
consistent with the time courses of virus production (Fig. 1).
On this basis we selected the time points of 5.5, 6, and 7.5 h p.i
for EV11, ParV1 and EMCV, respectively.
Next, we examined the RNA replication sites in the cells
infected with EMCV, ParV1, and EV11 and treated with 10-
g/ml BFA starting from 1 h p.i., or left untreated. The cells
were fixed at 7.5, 6, and 5.5 h p.i. for EMCV, ParV1, and EV11,
respectively, and stained for IF using an antibody directed
against dsRNA, which interacts with replicative forms of viral
RNA (26, 29, 54).
In the absence of BFA, the cytoplasmic distribution of the
RNA replication sites appeared to be similar between EMCV
and EV11, with numerous small foci of anti-dsRNA staining
concentrated in the perinuclear and juxtanuclear areas (Fig.
3A and E). In ParV1-infected cells the foci of anti-dsRNA
staining were larger and fewer than those observed in EMCV-
and EV11-infected cells; however, they were also concentrated
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in the perinuclear and juxtanuclear areas (Fig. 3C). The pat-
tern of EMCV dsRNA staining did not change in the presence
of BFA (Fig. 3B). The pattern of ParV1 dsRNA staining also
did not change, except for the reduction in the number of the
foci (Fig. 3D), consistent with the reduction in the virus yield
described above. In contrast, no dsRNA could be detected in
EV11 samples (Fig. 3F), consistent with the profound inhibi-
tion of replication of this virus by BFA.
Morphology of the replication complexes of EMCV, ParV1,
and EV11. As a first step towards defining the cellular factors
involved in the formation of the replication complexes (RCs)
of EMCV, ParV1 and EV11, we compared the morphology of
the RCs between the three viruses.
First, we utilized resin embedding and electron microscopy
of the cells infected for 7.5, 6 and 5.5 h with EMCV, ParV1 and
EV11, respectively, in the absence of BFA. Thus, we observed
that all three viruses induced a clustering of vesicles within the
perinuclear region of the cytoplasm (Fig. 4A to C), consistent
with previous reports for the viruses from the same genera (9,
19, 51). EMCV and EV11 induced similar assemblies of tightly
clustered vesicles (Fig. 4A and C). The vesicles within the
membranous structures induced by ParV1 were less tightly
clustered (Fig. 4B). Cells infected with any of the three viruses
appeared to contain neither visible Golgi bodies nor ordered
rough ER, which were readily observed in mock-infected cells
(data not shown).
To further examine possible structural differences between
the RCs formed by the three viruses we used cryo-IEM, which
allowed us to specifically visualize the RCs using the anti-
dsRNA antibody and gold-labeled conjugate. We observed
that in EMCV-infected cells, dsRNA was localized to electron-
dense structures within the induced vesicle clusters (arrow in
Fig. 4D). In EV11-infected cells dsRNA was localized to elec-
tron-dense structures within the vesicle clusters (arrows in Fig.
4F), similar to EMCV, but also to the membrane of the vesicles
(arrowheads in Fig. 4F). The vesicles in both EMCV and EV11
RCs were heterogeneous in size and appeared to have a poorly
defined outer membrane, possibly due to fusion with adjacent
vesicles or due to some modification of the lipid composition.
In contrast, ParV1 RCs comprised well-defined, homoge-
neously sized vesicles approximately 70 to 100 nm in diameter
and did not appear to contain the electron-dense structures
observed with EMCV and EV11 (Fig. 4E). dsRNA was asso-
ciated with the membrane of the induced vesicles.
Thus, the RCs of EMCV and EV11 appeared to have similar
morphology, consisting of clusters of poorly defined, hetero-
geneously sized vesicles with electron-dense structures,
whereas the ParV1 RCs were distinct, consisting of clusters of
well defined homogeneous vesicles without electron-dense
structures.
-COP colocalizes with EV11, but not EMCV, dsRNA at the
peak of RNA synthesis. Rust et al. have demonstrated that the
vesicles in PV replication complexes are homologous to the
vesicles of the anterograde membrane transport pathway (43).
Assuming that the same is true for all picornaviruses, the basis
of their differential sensitivity to BFA may reside in a stage of
the ER-to-Golgi pathway, which these vesicles are required to
reach for the formation of the RCs. Provided that budding of
COPII-coated vesicles from the ER is not affected by BFA (1,
35, 47, 53), it is logical to presume that enteroviruses may
require COPI-coated membranes, whereas cardio- and pare-
choviruses may use membranes at earlier stages of anterograde
transport. To test this hypothesis we examined whether a com-
ponent of COPI, -COP, colocalized with dsRNA in EMCV-,
EV11-, or ParV1-infected cells, using confocal IF microscopy
and cryo-IEM.
By confocal IF microscopy we observed that the foci of
anti--COP and anti-dsRNA staining in EMCV-infected cells
FIG. 1. Time course of EV11, ParV1, and EMCV production. BS-
C-1 cells were infected with EV11 (A), ParV1 (B), or EMCV (C) at an
MOI of 3 and treated with 10-g/ml BFA starting from 1 h p.i. (Œ) or
left untreated (E). Cells were harvested into culture medium at indi-
cated times, and virus yield was measured by plaque assay.
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did not colocalize, and indeed the distribution of the two mark-
ers was different: the areas of more intense anti--COP stain-
ing appeared to contain fewer anti-dsRNA foci (Fig. 5A to C).
ParV1 infection resulted in a strong reduction in anti--COP
staining, suggestive of dispersal of most COPI throughout the
cytoplasm (Fig. 5D to F). The low intensity of anti--COP
staining in ParV1-infected cells precluded observation of any
possible colocalization with dsRNA by confocal IF microscopy.
FIG. 2. Time course of EV11, ParV1, and EMCV RNA synthesis. BS-C-1 cells were infected with each virus at MOI of 3 and labeled with
[5,6-3H]uridine starting from 1 h p.i. Cytoplasmic RNA was extracted from the cells at indicated times (hours) after infection and analyzed by
formaldehyde-agarose gel electrophoresis and autoradiography. The positions of viral (V) and cellular ribosomal (28S and 18S) RNAs are marked
on the right. M, RNA extracted from mock-infected cells labeled with [5,6-3H]uridine for 10 h.
FIG. 3. Distribution of dsRNA in BS-C-1 cells infected with EMCV, ParV1, or EV11 in the absence or presence of BFA. Cells were infected
with EMCV (A and B), ParV1 (C and D), or EV11 (E and F) at an MOI of 3 and treated with 10-g/ml BFA starting from 1 h p.i. (B, D, and
F) or left untreated (A, C, and E). The cells were fixed at 7.5, 6, and 5.5 h p.i. for EMCV, ParV1, and EV11, respectively, and immunostained with
anti-dsRNA antibody and Alexa Fluor 488 conjugate.
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FIG. 4. Morphology of the replication complexes of EMCV, ParV1 and EV11. BS-C-1 cells were infected with EMCV (A and D), ParV1 (B
and E), or EV11 (C and F) at an MOI of 3; incubated for 7.5, 6, or 5.5 h, respectively; and then harvested and fixed for electron microscopy. (A
to C) Cells were embedded in Epon resin, and ultrathin sections were cut and stained with uranyl acetate and lead citrate. All viruses induced the
clustering of vesicles in the perinuclear region indicative of picornavirus RCs. Nu, nucleus. Bars, 1 m. (D to F) Ultrathin cryosections of infected
cells were immunolabeled with anti-dsRNA antibody and visualized with either 5-nm anti-IgG gold (D) or 10-nm protein A-gold (E and F). (D) In
EMCV-infected cells, labeling of dsRNA was localized to electron-dense structures (indicated by arrows) within the clusters of heterogeneous
vesicles. (E) ParV1-infected cells were labeled on clusters of homogeneous vesicles ranging in size between 70 and 100 nm. The anti-dsRNA
antibody appeared to specifically label the membrane of the vesicles. (F) EV11-infected cells displayed labeling of dsRNA within the clusters of
heterogeneous vesicles, associated with electron-dense structures (indicated by arrows), as for EMCV, and also with the membrane of the vesicles
(indicated by arrowheads). Bars, 200 nm.
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In contrast, the patterns of anti-dsRNA and anti--COP stain-
ing in EV11-infected cells were very similar, and partial colo-
calization of the two antibodies was observed (Fig. 5G to I).
When the infected cells were further examined by cryo-IEM,
the EMCV RCs did not contain -COP (small arrowheads in
Fig. 6A and B), although it was present on some vesicles in the
vicinity (large arrowheads in Fig. 6A and B). In contrast, both
ParV1 and EV11 RCs were colabeled with anti-dsRNA and
anti--COP antibodies (Fig. 6C-F).
These results suggested that COPI-coated vesicles may be
involved in the formation of replication complexes of EV11,
but not EMCV. The data for ParV1 are less conclusive. It
would appear that, like EV11, ParV1 also uses COPI-coated
membranes for assembly of the RCs. However, in contrast to
EV11, which appeared to redistribute COPI coats to the virus-
induced vesicular structures, ParV1 infection caused the dis-
persal of most COPI.
-COP colocalizes with EV11 dsRNA early in infection. A
hallmark of PV infection is the breakdown of the Golgi appa-
ratus soon after the start of formation of RCs (5). The trans-
Golgi marker -1,4-galactosyltransferase (GalT) has been
found within PV-induced membranes isolated from infected
cells late in infection (46), and it was suggested that Golgi
membranes may be used as a secondary source of vesicles for
RCs following Golgi apparatus disintegration (43). Taking this
into account we examined whether -COP colocalized with
dsRNA in EV11-infected cells early in infection, prior to dis-
integration of the Golgi complex. EMCV- and ParV1-infected
cells were also examined at early times p.i. for comparison.
Viral dsRNA is first detectable in the infected cells by IF at
4 h p.i. for EV11 and ParV1 and at 5 h p.i. for EMCV (data not
shown). Therefore, we examined whether -COP colocalized
with dsRNA in the infected cells at 4 h p.i. for EV11 and
ParV1, and at 5 h p.i. for EMCV, using confocal IF micros-
copy. The integrity of the Golgi complex was monitored in the
same experiments by double labeling of separate samples with
anti-dsRNA antibody and an antibody to a marker for the cis-
and medial-Golgi compartments, giantin.
No colocalization between -COP and dsRNA was observed
in EMCV- and ParV1-infected cells: the staining patterns of
-COP and dsRNA in EMCV-infected cells were not coinci-
dent (Fig. 7A to C), and ParV1 caused strong reduction in
FIG. 5. The distribution of -COP and dsRNA in cells infected with EMCV, ParV1, and EV11 visualized by confocal IF microscopy. Cells were
infected as in Fig. 4, then fixed and double-labeled with anti-dsRNA and anti--COP antibodies. (A, D, and G) Staining with anti--COP antibody
and Alexa Fluor 568 conjugate (red). (B, E, and H) Staining with anti-dsRNA antibody and Alexa Fluor 488 conjugate (green). (C, F, and I) Merge
of first two columns; the sites of colocalization of the two antibodies are highlighted in yellow. (A to C) EMCV-infected cells; no colocalization.
(D to F) ParV1-infected cells; strong reduction in anti--COP staining is obvious in comparison with an uninfected cell present in this sample. (G
to I) EV11-infected cells; partial colocalization of the two antibodies.
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FIG. 6. -COP is present within the RCs of ParV1 and EV11 but is absent from the RCs of EMCV. Cells were infected as in Fig. 4, then
harvested, processed for cryosectioning, and double-immunolabeled with anti-dsRNA (5-nm gold conjugate) and anti--COP (10-nm gold
conjugate) antibodies. In EMCV-infected cells (A and B) the two markers (large arrowheads indicating -COP and small arrowheads indicating
dsRNA) appeared distinct from each other. ParV1 (C and D)- and EV11 (E)-infected cells showed coincidental labeling as indicated by the arrows.
In panel E, anti--COP and anti-dsRNA antibodies are bound to a vesicular structure budding from a membrane in close proximity to the ER.
(F) Both anti--COP (large arrowhead) and anti-dsRNA (small arrowhead) antibodies within an EV11 RC, although not very close to each other.
Bars, 200 nm.
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-COP staining (Fig. 7D to F). In contrast, -COP partly
colocalized with dsRNA in EV11-infected cells at 4 h p.i.,
although the extent of colocalization was lower than that ob-
served at 5.5 h p.i. (compare Fig. 7I and 5I). The staining
pattern of giantin in cells infected with EV11 for 4 h was
similar to that in uninfected cells, suggesting that the Golgi
complex was still intact (data not shown).
These results suggested that COPI-coated vesicles may be
involved in the formation of the RCs of EV11 from the start of
RNA replication.
DISCUSSION
BFA has been shown to strongly inhibit RNA replication of
PV (an enterovirus) and a rhinovirus but to have no effect on
the replication of the cardiovirus EMCV (21, 33). In this study,
we have demonstrated that replication of the parechovirus
ParV1 is also partially resistant to the effect of BFA, although
not to the same extent as that of EMCV, whereas replication
of another enterovirus, EV11, is strongly inhibited by BFA,
like that of PV.
Replication complexes of EMCV and EV11 appeared to
have similar morphologies when examined by cryo-IEM, con-
sisting of clusters of heterogeneously sized, poorly defined
vesicles, with dsRNA localized mainly to electron-dense struc-
tures within the clusters. Such electron-dense structures have
previously been identified as the sites of PV RNA replication
(2). Replication complexes of ParV1 were distinct, consisting
of less tightly clustered, well-defined, homogeneous vesicles,
not containing electron-dense structures. dsRNA was associ-
ated with the membrane of the vesicles.
Despite their morphological similarity, the RCs of EMCV
and EV11 had a major difference in vesicle coating, which was
consistent with the different sensitivity of these viruses to BFA.
A component of the COPI coat, -COP, was observed
within the RCs of EV11 by cryo-IEM, and confocal IF micros-
copy demonstrated that the staining patterns of -COP and
dsRNA were similar and partly colocalized both early and late
FIG. 7. Distribution of -COP and dsRNA in the cells at early times in EMCV, ParV1, and EV11 infections. Cells were infected with EMCV
(A to C), ParV1 (D to F), or EV11 (G to I) at an MOI of 3. The infected cells were fixed at 5 h p.i. (EMCV) or 4 h p.i. (ParV1 and EV11),
double-labeled with anti-dsRNA and anti--COP antibodies, and visualized by confocal IF microscopy. (A, D, and G) Staining with anti--COP
antibody and Alexa Fluor 568 conjugate (red). (B, E, and H) Staining with anti-dsRNA antibody and Alexa Fluor 488 conjugate (green). (C, F,
and I) Merge of first two columns; the sites of colocalization of the two antibodies are highlighted in yellow.
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in EV11 infection, with the extent of colocalization being
higher late in infection. Since COPI continuously binds to and
dissociates from membranes with a half-life of less than 2 min
(J. F. Presley, C. Miller, K. Zaal, J. Ellenberg, and J. Lippin-
cott-Schwartz, abstr., Mol. Biol. Cell Suppl. 9:746, 1998), the
higher degree of association of COPI with EV11 RCs late in
infection, after disruption of the Golgi complex, may be due to
the increase in free cytoplasmic COPI caused by its release
from disintegrated Golgi membranes.
These results suggest that COPI association with mem-
branes may be required for the formation of the RCs of EV11
from the start of the replication cycle, a notion that can explain
the profound inhibition by BFA of the replication of EV11.
This hypothesis is supported by the previously published data
that PV RNA replication in vitro is dependent on ARF activity
(8).
It needs to be noted that in addition to COPI, BFA prevents
association with membranes of another ARF1-regulated coat
protein complex—clathrin--adaptin (40, 41, 55)—thus pre-
venting budding of clathrin--adaptin-coated vesicles from the
trans-Golgi network, endosomes, and lysosomes (10, 18). How-
ever, Doedens et al. have demonstrated that in cell lines in
which COPI association with membranes is not affected by
BFA, whereas clathrin--adaptin association is inhibited, PV
production is not affected by BFA (12). Therefore, clathrin--
adaptin-coated vesicles, even if present in the RCs of entero-
viruses, have no significant role in their formation.
Another possible cause of the inhibition of replication of
enteroviruses by BFA is Golgi complex disintegration and re-
distribution of Golgi lipids and enzymes into the ER, which is
the consequence of COPI dissociation from membranes. How-
ever, the integrity of the Golgi complex does not appear to be
important for the enterovirus RNA replication, since PV ves-
icles do not originate from nor fuse with the Golgi complex
early in infection (43), and the Golgi complex disintegrates
soon after the start of RNA synthesis (5). Redistribution of
Golgi lipids and enzymes into the ER also seems unlikely to
inhibit the formation of the RCs, because it does not affect
budding of COPII-coated vesicles from the ER (35, 47, 53).
Thus, our results, in combination with the published data,
strongly suggest that the formation of the RCs of enteroviruses
is dependent on COPI association with the vesicles, and the
inhibitory effect of BFA is due to prevention of such associa-
tion.
Our findings are consistent with the data of Rust et al. that
PV-induced vesicles bud from the ER by the COPII mecha-
nism and therefore are homologous to the vesicles of the
anterograde membrane transport pathway (43). We demon-
strate that a later step in this pathway, COPI binding, is also
required for the enterovirus RC formation. To the best of our
knowledge, there are no published data suggesting an associ-
ation of COPI with autophagy. Also, BFA does not interfere
with the formation of autophagy (34, 39). Taken together, this
argues against the autophagic mechanism for the formation of
virus-induced vesicles on the ER (9, 46, 50).
It is not clear at what stage of the ER-Golgi pathway the
RCs of enteroviruses are assembled. COPI coats are predom-
inantly found on VTC and Golgi membranes and are found
less so on the trans-Golgi network (reference 32 and references
therein). Also, in vitro experiments have shown that COPI can
be directly recruited to the vesicles after budding from the ER
(42). It is possible, therefore, that ER-derived vesicles may
acquire COPI coats prior to assembly into the RCs. Alterna-
tively, ER-derived vesicles may fuse into VTCs, and a second,
COPI-dependent budding step may be required for assembly
of the RCs.
In contrast to EV11, EMCV RCs did not contain -COP, as
visualized by cryo-IEM, and confocal IF microscopy demon-
strated segregation of the foci of staining of -COP and
dsRNA in EMCV-infected cells. Segregation of COPI from
the replication complexes of EMCV was consistent with the
observed resistance of EMCV to BFA.
These results suggest that RCs of EMCV are likely to be
formed immediately after vesicle budding from the ER, with-
out recruiting COPI coats. Budding of COPII-coated vesicles
from the ER is not affected by BFA (1, 35, 47, 53), which can
explain the insensitivity of EMCV replication to BFA.
ParV1 was distinct from EV11 and EMCV not only in the
morphology of the RCs but also in its effect on COPI associ-
ation with membranes. IF microscopy showed a strong reduc-
tion in -COP staining in ParV1-infected cells, starting from
early in infection, suggesting the dissociation of most COPI
from the membranes and dispersal throughout the cytoplasm.
Nevertheless, -COP could be detected within the ParV1 RCs
by cryo-IEM. These observations may mean that ParV1 RCs
are formed using COPI-containing membranes, but their for-
mation causes predominant dissociation of COPI rather than
its involvement in RC formation. This would be consistent with
the relative resistance of ParV1 to the effect of BFA. VTCs
might be the source of such membranes. They normally con-
tain COPI, and their formation is enhanced by COPI binding
(25), but they still can form when COPI binding is inhibited
(44, 53). The fourfold reduction in ParV1 yield in the presence
of BFA might reflect a corresponding reduction in VTC for-
mation. However, further studies are needed to test this hy-
pothesis.
ACKNOWLEDGMENTS
This work was supported in part by NHMRC fellowship 149502 and
project grant 149501 (D.A.A.) and by the Joe White Bequest and the
Research Fund of the Burnet Institute (E.V.G.).
We thank J.-Y. Lee and H.-P. Hauri for generously providing the
antibodies and J. Mak and R. Ghildyal for critical reading of the
manuscript.
REFERENCES
1. Bednarek, S. Y., M. Ravazzola, M. Hosobuchi, M. Amherdt, A. Perrelet, R.
Schekman, and L. Orci. 1995. COPI- and COPII-coated vesicles bud directly
from the endoplasmic reticulum in yeast. Cell 83:1183–1196.
2. Bienz, K., D. Egger, and L. Pasamontes. 1987. Association of polioviral
proteins of the P2 genomic region with the viral replication complex and
virus-induced membrane synthesis as visualized by electron microscopic im-
munocytochemistry and autoradiography. Virology 160:220–226.
3. Bienz, K., D. Egger, T. Pfister, and M. Troxler. 1992. Structural and func-
tional characterization of the poliovirus replication complex. J. Virol. 66:
2740–2747.
4. Bienz, K., D. Egger, M. Troxler, and L. Pasamontes. 1990. Structural orga-
nization of poliovirus RNA replication is mediated by viral proteins of the P2
genomic region. J. Virol. 64:1156–1163.
5. Bolten, R., D. Egger, R. Gosert, G. Schaub, L. Landmann, and K. Bienz.
1998. Intracellular localization of poliovirus plus- and minus-strand RNA
visualized by strand-specific fluorescent in situ hybridization. J. Virol. 72:
8578–8585.
6. Burgyan, J., L. Rubino, and M. Russo. 1996. The 5-terminal region of a
tombusvirus genome determines the origin of multivesicular bodies. J. Gen.
Virol. 77:1967–1974.
VOL. 76, 2002 COPI AND REPLICATION COMPLEXES OF PICORNAVIRUSES 11121
 o
n
 N
ovem
ber 19, 2015 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
7. Carette, J. E., M. Stuiver, J. Van Lent, J. Wellink, and A. Van Kammen.
2000. Cowpea mosaic virus infection induces a massive proliferation of
endoplasmic reticulum but not Golgi membranes and is dependent on de
novo membrane synthesis. J. Virol. 74:6556–6563.
8. Cuconati, A., A. Molla, and E. Wimmer. 1998. Brefeldin A inhibits cell-free,
de novo synthesis of poliovirus. J. Virol. 72:6456–6464.
9. Dales, S., H. J. Eggers, I. Tamm, and G. E. Palade. 1965. Electron micro-
scopic study of the formation of poliovirus. Virology 26:379–389.
10. De Lisle, R. C., and R. Bansal. 1996. Brefeldin A inhibits the constitutive-like
secretion of a sulfated protein in pancreatic acinar cells. Eur. J. Cell Biol.
71:62–71.
11. De Zoeten, G. A., G. Gaard, and F. B. Diez. 1972. Nuclear vesiculation
associated with pea enation mosaic virus-infected plant tissue. Virology
48:638–647.
12. Doedens, J., L. A. Maynell, M. W. Klymkowsky, and K. Kirkegaard. 1994.
Secretory pathway function, but not cytoskeletal integrity, is required in
poliovirus infection. Arch. Virol. Suppl. 9:159–172.
13. Doedens, J. R., and K. Kirkegaard. 1995. Inhibition of cellular protein
secretion by poliovirus proteins 2B and 3A. EMBO J. 14:894–907.
14. Donaldson, J. G., D. Finazzi, and R. D. Klausner. 1992. Brefeldin A inhibits
Golgi membrane-catalysed exchange of guanine nucleotide onto ARF pro-
tein. Nature 360:350–352.
15. Donaldson, J. G., R. A. Kahn, J. Lippincott-Schwartz, and R. D. Klausner.
1991. Binding of ARF and beta-COP to Golgi membranes: possible regula-
tion by a trimeric G protein. Science 254:1197–1199.
16. Donaldson, J. G., J. Lippincott-Schwartz, G. S. Bloom, T. E. Kreis, and R. D.
Klausner. 1990. Dissociation of a 110-kD peripheral membrane protein from
the Golgi apparatus is an early event in brefeldin A action. J. Cell Biol.
111:2295–2306.
17. Donaldson, J. G., J. Lippincott-Schwartz, and R. D. Klausner. 1991. Gua-
nine nucleotides modulate the effects of brefeldin A in semipermeable cells:
regulation of the association of a 110-kD peripheral membrane protein with
the Golgi apparatus. J. Cell Biol. 112:579–588.
18. Fernandez, C. J., M. Haugwitz, B. Eaton, and H. P. Moore. 1997. Distinct
molecular events during secretory granule biogenesis revealed by sensitivities
to brefeldin A. Mol. Biol. Cell 8:2171–2185.
19. Harb, J. M., and G. E. Burch. 1973. Ultrastructural cytopathology of mouse
myocardium associated with EMC viral infection. J. Mol. Cell Cardiol. 5:55–
62.
20. Helms, J. B., and J. E. Rothman. 1992. Inhibition by brefeldin A of a Golgi
membrane enzyme that catalyses exchange of guanine nucleotide bound to
ARF. Nature 360:352–354.
21. Irurzun, A., L. Perez, and L. Carrasco. 1992. Involvement of membrane
traffic in the replication of poliovirus genomes: effects of brefeldin A. Virol-
ogy 191:166–175.
22. King, A. M. Q., F. Brown, P. D. Christian, T. Hovi, T. Hyypia, N. J. Knowles,
S. M. Lemon, P. D. Minor, A. C. Palmenberg, T. Skern, and G. Stanway.
2000. Picornaviridae, p. 657–673. In M. H. V. van Regenmortel, C. M.
Fauquet, D. H. L. Bishop, C. H. Calisher, E. B. Carsten, M. K. Estes, S. M.
Lemon, J. Maniloff, M. A. Mayo, D. McGeoch, C. R. Pringle, and R. B.
Wickner (ed.), Virus taxonomy: classification and nomenclature of viruses.
Seventh report of the International Committee for the Taxonomy of Viruses.
Academic Press, San Diego, Calif.
23. Klumperman, J., A. Schweizer, H. Clausen, B. L. Tang, W. Hong, V. Oor-
schot, and H. P. Hauri. 1998. The recycling pathway of protein ERGIC-53
and dynamics of the ER-Golgi intermediate compartment. J. Cell Sci. 111:
3411–3425.
24. Lanoix, J., J. Ouwendijk, C. C. Lin, A. Stark, H. D. Love, J. Ostermann, and
T. Nilsson. 1999. GTP hydrolysis by arf-1 mediates sorting and concentration
of Golgi resident enzymes into functional COP I vesicles. EMBO J. 18:4935–
4948.
25. Lavoie, C., J. Paiement, M. Dominguez, L. Roy, S. Dahan, J. N. Gushue, and
J. J. Bergeron. 1999. Roles for alpha(2)p24 and COPI in endoplasmic retic-
ulum cargo exit site formation. J. Cell Biol. 146:285–299.
26. Lee, J. Y., J. A. Marshall, and D. S. Bowden. 1994. Characterization of
rubella virus replication complexes using antibodies to double-stranded
RNA. Virology 200:307–312.
27. Letourneur, F., E. C. Gaynor, S. Hennecke, C. Demolliere, R. Duden, S. D.
Emr, H. Riezman, and P. Cosson. 1994. Coatomer is essential for retrieval of
dilysine-tagged proteins to the endoplasmic reticulum. Cell 79:1199–1207.
28. Linstedt, A. D., M. Foguet, M. Renz, H. P. Seelig, B. S. Glick, and H. P.
Hauri. 1995. A C-terminally anchored Golgi protein is inserted into the
endoplasmic reticulum and then transported to the Golgi apparatus. Proc.
Natl. Acad. Sci. USA 92:5102–5105.
29. Mackenzie, J. M., M. K. Jones, and E. G. Westaway. 1999. Markers for
trans-Golgi membranes and the intermediate compartment localize to in-
duced membranes with distinct replication functions in flavivirus-infected
cells. J. Virol. 73:9555–9567.
30. Mackenzie, J. M., M. K. Jones, and P. R. Young. 1996. Immunolocalization
of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral
RNA replication. Virology 220:232–240.
31. Mackenzie, J. M., M. K. Jones, and P. R. Young. 1996. Improved membrane
preservation of flavivirus-infected cells with cryosectioning. J. Virol. Meth-
ods 56:67–75.
32. Martinez-Menarguez, J. A., H. J. Geuze, J. W. Slot, and J. Klumperman.
1999. Vesicular tubular clusters between the ER and Golgi mediate concen-
tration of soluble secretory proteins by exclusion from COPI-coated vesicles.
Cell 98:81–90.
33. Maynell, L. A., K. Kirkegaard, and M. W. Klymkowsky. 1992. Inhibition of
poliovirus RNA synthesis by brefeldin A. J. Virol. 66:1985–1994.
34. Ogier-Denis, E., C. Bauvy, J. J. Houri, and P. Codogno. 1997. Evidence for
a dual control of macroautophagic sequestration and intracellular trafficking
of N-linked glycoproteins by the trimeric G(i3) protein in HT-29 cells.
Biochem. Biophys. Res. Commun. 235:166–170.
35. Orci, L., A. Perrelet, M. Ravazzola, F. T. Wieland, R. Schekman, and J. E.
Rothman. 1993. “BFA bodies”: a subcompartment of the endoplasmic re-
ticulum. Proc. Natl. Acad. Sci. USA 90:11089–11093.
36. Orci, L., M. Stamnes, M. Ravazzola, M. Amherdt, A. Perrelet, T. H. Sollner,
and J. E. Rothman. 1997. Bidirectional transport by distinct populations of
COPI-coated vesicles. Cell 90:335–349.
37. Orci, L., M. Tagaya, M. Amherdt, A. Perrelet, J. G. Donaldson, J. Lippin-
cott-Schwartz, R. D. Klausner, and J. E. Rothman. 1991. Brefeldin A, a drug
that blocks secretion, prevents the assembly of non-clathrin-coated buds on
Golgi cisternae. Cell 64:1183–1195.
38. Pedersen, K. W., Y. van der Meer, N. Roos, and E. J. Snijder. 1999. Open
reading frame 1a-encoded subunits of the arterivirus replicase induce endo-
plasmic reticulum-derived double-membrane vesicles which carry the viral
replication complex. J. Virol. 73:2016–2026.
39. Purhonen, P., K. Pursiainen, and H. Reunanen. 1997. Effects of brefeldin A
on autophagy in cultured rat fibroblasts. Eur. J. Cell Biol. 74:63–67.
40. Robinson, M. S. 1990. Cloning and expression of gamma-adaptin, a compo-
nent of clathrin-coated vesicles associated with the Golgi apparatus. J. Cell
Biol. 111:2319–2326.
41. Robinson, M. S., and T. E. Kreis. 1992. Recruitment of coat proteins onto
Golgi membranes in intact and permeabilized cells: effects of brefeldin A
and G protein activators. Cell 69:129–138.
42. Rowe, T., M. Aridor, J. M. McCaffery, H. Plutner, C. Nuoffer, and W. E.
Balch. 1996. COPII vesicles derived from mammalian endoplasmic reticu-
lum microsomes recruit COPI. J. Cell Biol. 135:895–911.
43. Rust, R. C., L. Landmann, R. Gosert, B. L. Tang, W. Hong, H. P. Hauri, D.
Egger, and K. Bienz. 2001. Cellular COPII proteins are involved in produc-
tion of the vesicles that form the poliovirus replication complex. J. Virol.
75:9808–9818.
44. Scales, S. J., R. Pepperkok, and T. E. Kreis. 1997. Visualization of ER-to-
Golgi transport in living cells reveals a sequential mode of action for COPII
and COPI. Cell 90:1137–1148.
45. Schaad, M. C., P. E. Jensen, and J. C. Carrington. 1997. Formation of plant
RNA virus replication complexes on membranes: role of an endoplasmic
reticulum-targeted viral protein. EMBO J. 16:4049–4059.
46. Schlegel, A., T. H. Giddings, Jr., M. S. Ladinsky, and K. Kirkegaard. 1996.
Cellular origin and ultrastructure of membranes induced during poliovirus
infection. J. Virol. 70:6576–6588.
47. Shaywitz, D. A., L. Orci, M. Ravazzola, A. Swaroop, and C. A. Kaiser. 1995.
Human SEC13Rp functions in yeast and is located on transport vesicles
budding from the endoplasmic reticulum. J. Cell Biol. 128:769–777.
48. Stamnes, M. A., and J. E. Rothman. 1993. The binding of AP-1 clathrin
adaptor particles to Golgi membranes requires ADP-ribosylation factor, a
small GTP-binding protein. Cell 73:999–1005.
49. Stephens, D. J., N. Lin-Marq, A. Pagano, R. Pepperkok, and J. P. Paccaud.
2000. COPI-coated ER-to-Golgi transport complexes segregate from COPII
in close proximity to ER exit sites. J. Cell Sci. 113:2177–2185.
50. Suhy, D. A., T. H. Giddings, Jr., and K. Kirkegaard. 2000. Remodeling the
endoplasmic reticulum by poliovirus infection and by individual viral pro-
teins: an autophagy-like origin for virus-induced vesicles. J. Virol. 74:8953–
8965.
51. Trant, C. M., and R. M. Jamison. 1975. Electron microscopic study of the
morphogenesis of echovirus 23. Exp. Mol. Pathol. 22:55–64.
52. Tucker, S. P., C. L. Thornton, E. Wimmer, and R. W. Compans. 1993.
Vectorial release of poliovirus from polarized human intestinal epithelial
cells. J. Virol. 67:4274–4282.
53. Ward, T. H., R. S. Polishchuk, S. Caplan, K. Hirschberg, and J. Lippincott-
Schwartz. 2001. Maintenance of Golgi structure and function depends on the
integrity of ER export. J. Cell Biol. 155:557–570.
54. Westaway, E. G., J. M. Mackenzie, M. T. Kenney, M. K. Jones, and A. A.
Khromykh. 1997. Ultrastructure of Kunjin virus-infected cells: colocalization
of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in
virus-induced membrane structures. J. Virol. 71:6650–6661.
55. Wong, D. H., and F. M. Brodsky. 1992. 100-kD proteins of Golgi- and
trans-Golgi network-associated coated vesicles have related but distinct
membrane binding properties. J. Cell Biol. 117:1171–1179.
11122 GAZINA ET AL. J. VIROL.
 o
n
 N
ovem
ber 19, 2015 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
